# Wuhan Biocause Pharmaceutical Development Co., Ltd. – FDA Inspection, Mar 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/cf0802f0-fbd5-4ef6-8a2f-51da576523d8
Source feed: FDA_Inspections

> FDA inspection 1267912 of Wuhan Biocause Pharmaceutical Development Co., Ltd., March 14, 2025. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1267912
- Company Name: Wuhan Biocause Pharmaceutical Development Co., Ltd.
- Inspection Date: 2025-03-14
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 0

## Related Documents

- [FDA Inspection 1069379 - 2018-08-24](https://www.keypedia.com/records/fda_inspections/wuhan-biocause-pharmaceutical-development-co-ltd/58c8650e-e596-4fd1-a0ef-b54e39889c78)
- FDA Inspection 982641 - 2016-07-22
- FDA Inspection 873586 - 2014-02-28
- FDA Inspection 680329 - 2010-07-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)

Company: https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8